1. ReportLinker Data
  2. Life Sciences
  3. Pharmaceutical
  4. Pharmaceutical Exports
  5. Export of Antisera and O…

Export of antisera and other blood fractions from Belarus declines in 2016

The indicator declined by 13.97 percent in comparison to the prior year, according to updated figures presented by United Nations Statistical Office. Pharmaceutical export decreased from 916 300 US Dollar in 2015 to 788 300 US Dollar previous year, as it follows the tendency of the prior year when it dropped by 15.68 percent. Belarus saw a rise of 322.23% in pharmaceutical export during the last 19 years. As well as it has attained a growth at a 0.09% CAGR during the last five years with a modest overall raise since the 1998. It averaged 340 104.84 US Dollar from 1998 to 2016 and it reached its all-time high of 1 388 600 US Dollar in 2013 and record low of 19 595 US Dollar in 1999.

Export of antisera and other blood fractions from Belarus declines in 2016
Date US Dollar Variation
2016 788 300.00 -13.97
2015 916 300.00 -15.68
2014 1 086 700.00 -21.74
2013 1 388 600.00 167.5
2012 519 100.00 59.77
2011 324 900.00 17.93
2010 275 500.00 129.58
2009 120 000.00 -33.37
2008 180 100.00 177.5
2007 64 900.00 -3.85

Related Statistics

Pharmaceutical Exports in other Countries

Main Pharmaceutical Indicators

  • Pharmaceutical Imports

  • Pharmaceutical Exports

  • Medicine Use

    Use of medicines, usually meadured in in defined daily dosis (DDD) per day. The DDD consists of the assumed average maintenance dose per day for a drug used for its main indication in adults. Based on: World Health Organization.

  • Pharmaceutical Production

    Manufacture of basic pharmaceutical products and pharmaceutical preparations in million units of national currency or in volume index of production.

  • Pharmacist Density

  • Spending On Medicines

    Measures total value of spending on prescription medicines and insulins by retail pharmacies, hospitals, and other institutional pharmacies at invoice prices.

  • Re-Imbursed Pharmaceutical

    Share of re-imbursed medication in the pharmaceutical market, usually expressed in percentage of medication sales or in value of reimbursements (thousands or millions of national currency). It can be measured separately for generic medication and brand-name medication, or for the whole market. Based on: Organisation for Economic Co-operation and Development.

  • Pharmaceutical Registrations

  • Pharmaceutical Revenue

    Revenue of pharmaceutical industry. The latter is comprised of companies engaged in researching, developing, manufacturing and distributing drugs for human or veterinary use. Based on: United States Department of Commerce.

  • Drug Store Retail Sales